Pelthos Therapeutics PTHS
NYSE PTHS
$20.77 +0.11 (+0.53%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pelthos Therapeutics (PTHS) Price to Sales (2025 - 2026)

Updated

Pelthos Therapeutics' Price to Sales was 2.43 in Q2 2026, down 5.1% from the prior quarter.

Analysis

Pelthos Therapeutics (PTHS) Price to Sales (2025 - 2026) Analysis & Trends

For FY2025, Price to Sales at Pelthos Therapeutics came in at 3.47.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Pelthos Therapeutics 77.24 Mn -11.16 Mn 11.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.43
Mar 31, 2026 2.56
Dec 31, 2025 3.47
API Access

Pelthos Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=PTHS&period=max&api_key=YOUR_API_KEY